Ref (type) | Population | Outcome, Interventions | Results and statistical analysis | Effect size | Favours |
Delirium | |||||
RCT 3-armed trial |
30 people admitted to hospital with advanced AIDS In review |
Change in delirium from baseline (measured by Delirium Rating Scale; lower scores indicate better function)
2 days
17.33 with lorazepam 18.33 with baseline Absolute results not reported |
No direct comparison between groups P = 0.63 for change from baseline with lorazepam |
||
RCT 3-armed trial |
30 people admitted to hospital with advanced AIDS In review |
Change in delirium with longer treatment (measured by Delirium Rating Scale; lower scores indicate better function)
between 2 and 7 days
17.33 with lorazepam at 2 days 17.0 with lorazepam at 7 days Absolute results not reported |
No direct comparison between groups reported P = 0.81 for change between 2 and 7 days with lorazepam |
||
RCT 3-armed trial |
30 people admitted to hospital with advanced AIDS In review |
Cognition (measured by the Mini-Mental State Examination; higher scores indicate better function)
2 days
12.67 with lorazepam 15.7 with baseline Absolute results not reported |
No direct comparison between groups reported P = 0.40 for change from baseline with lorazepam |